logo
Two states are coming after a New York doctor for mailing abortion pills. Here's what's next.

Two states are coming after a New York doctor for mailing abortion pills. Here's what's next.

Yahoo14-02-2025
Since the fall of Roe v. Wade, tens of thousands of people in states with abortion bans have continued to access the procedure through telehealth. But two separate cases targeting a New York physician could test the laws put in place to protect doctors who prescribe and mail abortion medications, jeopardizing the future of abortion access across the country.
Dr. Margaret Carpenter has allegedly prescribed and mailed abortion pills to patients in Texas and Louisiana, both states where abortion is almost completely illegal. Texas Attorney General Ken Paxton has filed a civil lawsuit accusing Carpenter of practicing medicine in Texas without a license and violating the state's abortion ban. In Louisiana, a grand jury has indicted Carpenter on criminal charges for allegedly violating the state's abortion ban.
The cases test statutes known as shield laws, which have been passed in eight states since the end of Roe. The laws — enacted in California, Colorado, Maine, Massachusetts, New York, Rhode Island, Vermont and Washington — say that the state government will not comply with civil or criminal prosecutions targeting health care providers who perform abortions from their home states, including mailing medication to patients in places where the procedure is outlawed.
Those laws have enabled many people to receive abortions despite living in places with abortion bans. The Society for Family Planning estimates that close to 10,000 people in states with bans or restrictions get care through shield laws each month; between the start of 2023 and March 2024, it was more than 65,000 people. Research shows that providing abortion through telehealth, using the medications mifepristone and misoprostol, is highly safe and effective through the first trimester.
In Texas, a county judge issued an order Thursday blocking Carpenter from sending abortion medications to the state and fining her $100,000. Carpenter did not attend the hearing. The same day, New York Gov. Kathy Hochul, in compliance with her state's shield law, rejected a request from Louisiana's Republican governor to extradite Carpenter.
'The ruling in Texas does not change that under Shield Laws, patients can access medication abortion from licensed providers no matter where they live. New York, led by Governor Hochul, remains committed to protecting this care,' Julie Kay, a lawyer who, along with Carpenter and New York-based shield law provider Dr. Linda Prine, co-founded the Abortion Coalition for Telemedicine, said in a statement. Carpenter has not been reachable for comment. Prine declined to comment. Kay's remarks were in a written statement.
Kay added that the Louisiana case is 'inconsistent with New York state law,' and said the coalition will keep defending shield laws like New York's.
The cases represent a remarkable evolution from less than three years ago, when, soon before Roe's overturn, Republicans argued that they would not support policies that could put doctors in prison.
'The attempts to punish a provider who was providing what I understand to be legal care in her state for a patient who desired an abortion is aggressive and threatening,' said Dr. Jonas Swartz, an OB-GYN and abortion provider in North Carolina. 'We've become desensitized to it, but it's a really big deal.'
What comes next is the first test of the relatively new shield law infrastructure and the health care model it has enabled. These cases likely will not halt telehealth abortion immediately. But they are expected to yield complex, drawn-out legal battles — one that could end up in the U.S. Supreme Court — with vast possible ramifications.
Abortion opponents have voiced frustration with the prevalence of shield laws, and the workaround they've provided for patients seeking abortions. In Texas, anti-abortion activists are pushing for legislation to stop this practice. John Seago, the head of Texas Right to Life, has suggested that more cases, similar to the one against Carpenter, are in the pipeline.
There is a risk that cases like Louisiana's and Texas' could deter some providers from offering care through shield laws, Swartz suggested. But others who have been providing telehealth abortion — and relying on shield laws to do so — said previously that individual state-based legal actions would not necessarily stop them.
'We all have gone into this eyes wide open that we knew there would be legal challenges,' Dr. Angel Foster, a physician who co-founded a shield law practice called the Massachusetts Medication Abortion Project, told The 19th in early February. 'We're so confident what we're doing is legal in the state of Massachusetts. Our practice complies with all laws, policies and regulations in the Commonwealth, so we continue to provide legally compliant, high-quality affordable abortion care, and will continue to do so.'
A California-based shield law physician, who asked that his name be withheld because of threats of violence against abortion providers, expressed similar confidence.
'I comply with California law to the letter and the spirit,' he said. 'As long as it's legal and ethical to provide these services, I can do so irrespective of other states' actions.'
New York's law is likely to prevent enforcement of Texas' judgment, as long as Carpenter physically stays out of the Lone Star State, argued David Cohen, a constitutional law scholar at Drexel University who has advised many states on the construction of their shield laws.
'This case is very clear,' he said. 'Dr. Carpenter would be on incredibly strong ground here and never have this judgment enforced against her in New York state court.'
New York's shield law clearly says that the state will not extradite someone for providing an abortion if they did so while physically in the state. Because Louisiana alleges that Carpenter mailed medication to the patient — and did not come to Louisiana to do so — the Empire State is unlikely to comply.
Still, Carpenter could be at risk of extradition to Louisiana if she goes to another state, Cohen said, because the shield law's protections only apply within New York's borders. 'If I were Dr. Carpenter, I would not leave the state of New York,' he said.
The Texas and Louisiana cases will likely progress to other courts.
Texas could ask a New York state court to enforce its judgment against Carpenter. But New York will likely argue that the shield law prevents it from doing so. The case would likely continue to progress through the state's courts, and could possibly then be litigated in federal court — one with jurisdiction over New York.
Louisiana's case would likely take a similar route, Cohen said. The state could pursue its extradition request in New York state court or, eventually, in federal court. Lawyers for the state could seek intervention from the Supreme Court as well.
That process could take months or even years, involving questions of state extradition and jurisdiction that have not been litigated in more than 150 years. Some observers believe the case could be resolved at the Supreme Court.
Some suggested that a greater threat to broader telehealth than these court cases would be any federal action meant to disrupt shield laws. When federal and state laws conflict, federal laws typically triumph.
President Donald Trump said on the campaign trail that he did not want to take federal action to restrict abortion, saying instead that the issue should be left up to individual states. But earlier this month, Attorney General Pam Bondi said she would 'love to work with' Louisiana prosecutors to stop shield law-backed health care.
It's not clear what that might look like in practice. The Justice Department does not play a role in resolving disputes over extradition, Cohen said, and could not on its own compel New York to satisfy Louisiana's request.
But one avenue for federal action could be launching a separate case and invoking an 1873 anti-vice law called the Comstock Act, which has not been enforced in decades but was never repealed. Anti-abortion activists believe it could be used to halt mailing of abortion medications.
Under President Joe Biden, the Justice Department said it did not believe Comstock prohibited mailing these pills. But abortion opponents have been pressing the Trump administration to change that policy. The Supreme Court's most conservative members, Justices Samuel Alito and Clarence Thomas, have also expressed openness to that legal interpretation.
That approach, too, could spark its own legal battle.
'If there was any meaningful reinterpretation [of Comstock], I think lawsuits would be fast and furious,' Foster said.
The post Two states are coming after a New York doctor for mailing abortion pills. Here's what's next. appeared first on The 19th.
News that represents you, in your inbox every weekday. Subscribe to our free, daily newsletter.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Surf therapy offers tranquil setting for those dealing with mental health issues. Here's how it works.
Surf therapy offers tranquil setting for those dealing with mental health issues. Here's how it works.

CBS News

time42 minutes ago

  • CBS News

Surf therapy offers tranquil setting for those dealing with mental health issues. Here's how it works.

Some people are hitting the water to deal with mental health issues. In the latest installment in our "Breaking the Stigma" series, CBS News New York's Cindy Hsu went to the beach in the Rockaways to learn more about surf therapy. Gina Jurlando is the founder of "Ride the Tide," which offers a unique setting for surf therapy. "I have been a surfer my whole life. I've been in and out of traditional therapy my whole life," Jurlando said, "and sometimes I felt like I just didn't want to talk. I just wanted to do something that was calming, or, you know, talk about things in the lens of surfing." Jurlando says surf therapy can help people who struggle with anxiety and depression, PTSD, women who've experienced sexual trauma, and even children who've experienced loss. Sessions include a land component that encompasses art, discussions and a yoga-like warmup before hitting the waves. "Even getting to the beach sometimes can be a challenge for people dealing with certain mental health issues," surf therapy facilitator Ashley Fallon said. "We talk about challenging yourself when you're in this program, as you're comfortable, and that's what these programs can be as a way to kind of move past any blocks that you might be having." For Sharon Lew, Mick Arieta, and Narisara Vanichanan, one recent session was a day of warm sand, soft rolling waves, restorative movement and supportive affirmations. "I really had this, like, mental, like, clarity that I hadn't had in a very long time," Lew said. "I struggle with depression. I don't always get a chance to get out the door, right? I feel like it's in a safe space in a community that's not judgmental," Arieta said. "It just kind of helps wash away, you know, some of the all these other emotions," Vanichanan added. Therapists say surf therapy should not be a first line treatment for mental health issues, but add research supports that being in and around water does provide positive changes in social connectedness and depressive symptoms. "At the end of the session, I feel like just more calm. It's just like a switch that turns on," Arieta said. "It sounds corny, but feel one with it. There is just a sense of peace that happens," Lew said. "It stays with you, for me, the rest of the day, you know? Into my relationships, into my work. I think it's part of healthy self care, which, you know, doesn't get talked about enough," Vanichanan added. There are mental health practitioners, surf therapy facilitators and safety volunteers at all sessions. Ride the Tide has locations in Rockaway and Asbury Park, New Jersey, and a sliding scale of fees ranging from pay-what-you-can to $75 for a private, two-hour session.

Tennis Hall of Famer Monica Seles opens up on myasthenia gravis diagnosis
Tennis Hall of Famer Monica Seles opens up on myasthenia gravis diagnosis

Yahoo

time2 hours ago

  • Yahoo

Tennis Hall of Famer Monica Seles opens up on myasthenia gravis diagnosis

NEW YORK — Tennis great Monica Seles has revealed she was diagnosed with myasthenia gravis — a chronic neuromuscular autoimmune disease, also known as MG — three years ago. Ahead of the 2025 U.S. Open, which kicks off next week in Flushing Meadows-Corona Park, the 51-year-old Hall of Famer opened up about her health journey for the first time. 'It took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot,' she told the Associated Press. Seles — whose career included nine Grand Slam titles, seven of them before she turned 19 — revealed she was referred to a neurologist after first noticing symptoms such as double vision and weakness in her arms and legs. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' said the Yugoslavia native. She added that everyday activities like blowing out her hair 'became very difficult' as a result. Seles said she plans to attend the U.S. Open later this month, in partnership with an event with immunology company Argenx aimed at raising awareness about MG. According to the Cleveland Clinic, myasthenia gravis can also target muscles in the face and neck with symptoms including difficulty speaking, swallowing or chewing. MG happens when the body's immune system mistakenly attacks itself, though the cause of the condition is unclear. 'Studies suggest that certain immune system cells in your thymus gland have trouble identifying what's a threat to your body (like bacteria or viruses) versus healthy components,' the clinic adds. MG is incurable, according to the National Institute of Neurological Disorders and Stroke, but can be treated through thymus gland removal surgery, lifestyle changes and more.

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

Yahoo

time3 hours ago

  • Yahoo

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 3.6% in the afternoon session after the disclosure of significant stock sales by top executives, including CEO Andrew Dudum. According to SEC filings, CEO Andrew Dudum sold 660,000 shares for a total of approximately $33.4 million. The selling was not limited to the CEO, as Chief Medical Officer Patrick Carroll also sold 60,000 shares valued at around $3.2 million, while the company's chief commercial officer also recently parted with shares. Such significant stock sales by a company's top leadership can raise concerns among investors about the firm's future prospects. These transactions come at a challenging time for the telehealth company, which has recently faced legal pressure from drugmaker Novo Nordisk and a class-action lawsuit related to its compounded weight-loss drug offerings. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Hims & Hers Health? Access our full analysis report here, it's free. What Is The Market Telling Us Hims & Hers Health's shares are extremely volatile and have had 95 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 4 months ago when the stock gained 34.9% on the news that Novo Nordisk announced plans to offer its weight loss drug Wegovy through Hims & Hers Health's platform, expanding access to one of its fastest-growing products. By partnering with a popular telehealth company, Novo could speed up Wegovy's adoption, leading to more prescriptions. For investors, the deal signals a clear strategy to expand distribution and grab more market share, a move that could also boost sales growth for Hims & Hers (HIMS). Hims & Hers Health is up 91.4% since the beginning of the year, but at $48.23 per share, it is still trading 29.8% below its 52-week high of $68.74 from February 2025. Investors who bought $1,000 worth of Hims & Hers Health's shares 5 years ago would now be looking at an investment worth $4,541. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store